Safety study of VV913 capsules in healthy male volunteers
Treatments studied
This early-phase trial tests VV913 capsules in healthy men to see how safe they are and how the body processes the drug. It may help find the right dose for future studies.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a man aged 18 to 45 years old.
- You weigh at least 110 pounds and your body mass index is between 19 and 26.
- You are in good general health with no major medical conditions or abnormal test results.
- You agree to use effective birth control during the study and for 3 months after.
- You have not taken any prescription, over-the-counter, or herbal medicines in the past 2 weeks.
- You do not smoke more than 5 cigarettes a day and can avoid smoking and alcohol during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new capsule called VV913 in healthy male volunteers to see how safe it is and how the body processes it. It is a first-in-human trial in China to gather basic safety information.
This trial tests a new tablet called VV261 in healthy volunteers to see how safe it is and how the body processes it. It is an early study to gather important information before larger trials.
This study tests a new medicine called VV261 in healthy volunteers. It looks at whether the medicine is safe and how the body handles it. You may be able to join if you are a healthy adult aged 18-45 and meet certain health requirements.
This study tests how eating food changes how your body absorbs a new experimental drug called VV913. Researchers will give you the drug with and without food to see if meals make a difference in how well it works.
This trial studies how food changes the way your body processes a new medicine called VV119. It helps make sure the drug works safely and effectively. Healthy adults are needed to participate.
This early-stage study tests a new experimental drug called LG-0317 in healthy volunteers to see if it is safe and how the body processes it. If you are healthy and meet the basic requirements, this trial may help advance a new treatment option.
Hear when a new Healthy Volunteers trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.